The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Jiangsu Hengrui Medicine
Pyrotinib or lapatinib plus capecitabine for HER2+ metastatic breast cancer (PHOEBE): A randomized phase III trial.
 
Binghe Xu
Speakers' Bureau - AstraZeneca; Eisai; Pfizer; Roche
Research Funding - Jiangsu Hengrui Medicine (Inst)
 
Min Yan
No Relationships to Disclose
 
Fei Ma
No Relationships to Disclose
 
Xi-Chun Hu
No Relationships to Disclose
 
Ji Feng Feng
No Relationships to Disclose
 
Quchang Ouyang
No Relationships to Disclose
 
Zhongsheng Tong
No Relationships to Disclose
 
Huiping Li
No Relationships to Disclose
 
Qingyuan Zhang
No Relationships to Disclose
 
Tao Sun
No Relationships to Disclose
 
Xian Wang
Research Funding - Eddingpharm; Fuhonghanlin; Hengrui Pharmaceutical
 
Yongmei Yin
No Relationships to Disclose
 
Ying Cheng
No Relationships to Disclose
 
Wei Li
No Relationships to Disclose
 
Xiaoyu Zhu
Employment - Jiangsu Hengrui Medicine
 
Chunxia Chen
Employment - Hengrui Pharmaceutical
 
Jianjun Zou
No Relationships to Disclose